Israel Stocks: Teva, Delek Group, Mazor Robotics, Isramco

Israel’s TA-25 Index (TA-25) dropped the most in almost a week, retreating 0.7 percent to 1,086.19 at the 4:30 p.m. close in Tel Aviv. The measure has declined 18 percent this year. Investors traded about 578 million shekels ($152 million) of shares and convertible securities, according to bourse data.

The following stocks rose or fell today. Symbols are in parenthesis.

Ampal-American Israel Corp. (AMPL) declined 2.5 percent, the most in almost a week, to 1.461 shekels. Ampal, which owns a 12.5 percent stake in East Mediterranean Gas Co., an exporter of gas from Egypt to Israel, said the section of an Egyptian gas pipeline that was attacked today in a 10th such attack this year, was empty at the time of the explosion.

Isramco Negev 2 LP (ISRAL IT) gained 2.1 percent to 0.49 shekel, the highest level since Nov. 10. Israel Electric Corp.’s board of directors approved a 15-year deal that includes an $8 billion commitment to buy natural gas from the Tamar partnership. Ratio Oil Exploration 1992 LP (RATIL) advanced 1.2 percent to 0.337 shekel, the highest level since Dec. 13. Delek Group Ltd. (DLEKG) increased 0.1 percent to 700.30 shekels.

Mazor Robotics Ltd. (MZOR) rose to its highest since Nov. 2, increasing 3.7 percent to 4.45 shekels. The developer of surgical robots said it signed a sales contract with private U.S. medical clinics.

Scailex Corp. (SCIX) declined to the lowest level since October 2003, retreating 7.6 percent to 16.65 shekels. Standard and Poor’s Maalot lowered the bonds of the Israeli mobile-phone distributor to ilBBB+ from ilA-.

Teva Pharmaceutical Industries Ltd. (TEVA) climbed to the highest level since July 20, gaining 2.8 percent to 162.90 shekels or the equivalent of $42.89. The U.S.-traded shares of the world’s largest generic drug maker gained 0.7 percent to $42.72 on Dec. 16.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.